Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
Contacts
Capabilities
Suggested News & Insights
Bay Area Life Sciences RoundtableWednesday, July 22, 2026Sidley & Life Science Cares Reception at BIO 2026Monday, June 22, 2026Boston Life Sciences RoundtableTuesday, June 9, 2026Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

